Immunomedics Seeks $14M as Bridge to Milestones

Immunomedics Inc. went small with its first financing in more than five years, pricing an underwritten public offering of 6.1 million shares at $2.30 each – a 15 percent discount to Thursday's closing price – and seeking to raise just $14 million.